PILGRIMS PRIDE CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data PILGRIMS PRIDE CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	9,879	10,768	10,938	11,409	12,092	14,777	17,468	17,362	17,878	18,498
Cost of revenue	8,775	9,296	10,094	10,339	11,254	13,412	15,657	16,244	15,566	16,139
Gross profit	1,104	1,472	843	1,070	838	1,366	1,812	1,118	2,313	2,358
Research and development	3.5	3.7	4	5.1	5.4	5.1	12.5	5.7	12.4	17.9
Selling, general and administrative	311	390	343	380	593	1,149	605	552	713	713
Operating income	792	1,072	496	691	245	211	1,177	522	1,506	1,614
Interest expense	75.6	107	163	133	126	146	153	202	161	161
Interest income	2.3	7.73	13.8	14.3	7.31	6.06	9.03	35.7	72.7	51.1
Other non-operating income	9.34	6.54	2.7	-4.63	39.7	11.6	23.3	30.1	-15.3	5.65
Pre-tax income	724	982	332	618	162	92.4	1,025	365	1,412	1,502
Income tax	244	264	85.4	161	66.8	61.1	279	42.9	325	419
Net income to minority interests	-0.8	0.1	-1.14	0.61	0.31	0.27	0.61	0.74	0.79	0.99
Net income	441	695	248	456	94.8	31	746	322	1,086	1,082
EBITDA	1,024	1,344	770	978	583	592	1,580	942	1,940	2,070
EPS, basic	1.74	2.79	1.00	1.83	0.39	0.13	3.11	1.36	4.58	4.56
EPS, diluted	1.73	2.79	1.00	1.83	0.39	0.13	3.10	1.36	4.57	4.54
Shares, basic (weighted)	254	249	249	249	246	244	240	237	237	237
Shares, diluted (weighted)	254	249	249	250	246	244	240	237	238	238

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	293	582	338	261	548	428	401	698	2,041	640
Short-term investments								0	10.2	0
Receivables	446	565	562	741	742	1,013	1,097	1,129	1,004	1,165
Inventory	976	1,255	1,160	1,384	1,359	1,576	1,990	1,985	1,783	2,031
Other current assets	81.9	103	112	132	183	238	211	196	201	273
Total current assets	1,810	2,516	2,235	2,598	2,903	3,306	3,892	4,204	5,120	4,237
Property, plant and equipment	1,834	2,095	2,162	2,592	2,657	2,918	2,941	3,158	3,138	3,533
Lease right-of-use assets				302	289	351	306	267	256	258
Goodwill	887	1,002	950	974	1,005	1,337	1,228	1,286	1,239	1,339
Intangible assets	472	617	564	596	590	963	846	854	806	832
Other non-current assets	19.3	18.2	16.7	36.3	24.8	32.4	41.6	35.6	62	113
Total assets	5,022	6,249	5,931	7,102	7,474	8,913	9,256	9,810	10,651	10,344
Accounts payable	790	733	828	994	1,029	1,378	1,588	1,295	1,269	1,400
Accrued liabilities	347	410	389	575	808	860	851	927	1,016	1,096
Deferred revenue		36.6	33.3	41.8	65.9	22.3	34.5	85	48.9	37.6
Short-term debt	15.7	47.8	30.4	26.4	25.5	26.2	26.3	0.67	0.86	0.92
Total current liabilities	1,185	1,453	1,296	1,648	1,938	2,391	2,570	2,496	2,552	2,890
Long-term debt	1,414	2,662	2,322	2,276	2,256	3,191	3,166	3,341	3,206	3,093
Lease liabilities				235	217	271	231	203	196	199
Other non-current liabilities	103	96.4	75.1	97.1	149	102	71	40.2	20	14.8
Total liabilities	2,936	4,393	3,912	4,566	4,899	6,324	6,402	6,466	6,397	6,650
Total debt	1,430	2,709	2,353	2,276	2,256	3,191	3,166	3,342	3,207	0.92
Paid-in capital	3,100	1,933	1,945	1,955	1,954	1,964	1,970	1,979	1,994	2,024
Retained earnings	-783	174	422	878	973	1,004	1,749	2,071	3,158	2,246
Treasury stock	-217	-232	-232	-235	-345	-345	-545	-545	-545	-545
Other comprehensive income	-330	-31.1	-128	-75.1	-20.6	-48	-336	-176	-370	-47
Shareholders' equity	2,078	1,846	2,010	2,526	2,564	2,577	2,841	3,331	4,239	3,680
Minority interests	8.27	9.51	9.79	10.4	11.6	11.9	12.5	13.2	14	13.7
Total equity	2,086	1,856	2,020	2,536	2,575	2,589	2,853	3,345	4,253	3,694
Total liabilities and equity	5,022	6,249	5,931	7,102	7,474	8,913	9,256	9,810	10,651	10,344
Shares outstanding	249	249	249	250	244	244	236	237	237	238

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	480	718	247	457	95.1	31.3	747	322	1,087	1,083
Depreciation and amortization	232	272	274	287	337	381	403	420	434	456
Stock-based compensation	6.1	3.02	13.2	10.1	-0.28	11.7	6.99	7.23	14.9	29.4
Deferred income tax	-5.03	-50	32.5	42.5	37.3	-86.4	21.3	6.68	4.83	10
Change in receivables	-32.4	-82.2	-10.9	-25	29.2	-259	-150	-19	88.3	-113
Change in inventory	-33.1	-207	83.2	-112	26	-178	-472	12.6	135	-194
Change in payables	75.9	-22.8	86.8	120	295	360	263	-68.7	127	156
Cash from operations	795	801	492	667	724	326	670	678	1,990	1,372
Capital expenditures	-341	-340	-349	-348	-355	-382	-487	-558	-459	-719
Acquisitions	0	-659	0	-385	-4.22	-967	-9.69	0	0
Purchases of investments	0
Sales and maturities of investments	0
Cash from investing	-328	-992	-339	-717	-327	-1,324	-445	-503	-461	-706
Debt issued	593	1,872	748	259	405	2,952	363	1,768	0	0
Debt repaid	-570	-629	-1,117	-290	-431	-2,006	-388	-1,616	-152	-115
Dividends paid	-715	0	0					0	0	-1,994
Cash from financing	-828	466	-384	-34.5	-137	901	-232	117	-151	-2,113
Exchange rate effect	-38.6	16.4	3.53	4.07	7.29	-2.34
Net change in cash	-399	292	-228	-81	268	-98.3	-15.4	296	1,312	-1,403
Free cash flow	454	461	143	318	369	-55.2	183	120	1,532	653
Interest paid	69.9	81.3	155	131	131	119	156	131	182	155
Income taxes paid	161	123	254	126	51.7	20.9	386	19.7	198	362

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 28, 2026; growth uses fiscal years. Valuation uses the share price of $27.82 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	9.6%	Gross profit / revenue.
Operating margin	5.0%	Operating income / revenue.
EBITDA margin	7.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	4.3%	Pre-tax income / revenue.
Net margin	3.0%	Net income / revenue.
FCF margin	4.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.6%	Cash from operations / revenue.
Effective tax rate	30.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	14.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	5.4%	Net income / average total assets.
Return on invested capital (ROIC)	19.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	4.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.7%	Capital expenditures / revenue.
D&A / revenue	2.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	1.9%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	8.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	2.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	9.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	23.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	7.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	11.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	45.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	6.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	9.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	28.9%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-0.4%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	13.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	62.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-0.7%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	13.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	63.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-31.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	27.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	13.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-57.4%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	52.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	12.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-13.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	9.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	7.5%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-2.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.36x	Current assets / current liabilities.
Quick ratio	0.14x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.14x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.00x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	0.0%	Total debt / total assets.
Liabilities / assets	62.5%	Total liabilities / total assets.
Net debt	-$387.9M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.28x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	5.61x	Operating income / interest expense.
Working capital	$975.3M	Current assets - current liabilities.
Goodwill and intangibles / assets	21.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.64B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.84x	Revenue / average total assets.
Fixed asset turnover	4.90x	Revenue / average property, plant and equipment.
Inventory turnover	8.23x	Cost of revenue / average inventory.
Days inventory	44 days	365 x average inventory / cost of revenue.
Days payables	32 days	365 x average accounts payable / cost of revenue.
FCF conversion	134.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	40.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.28	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$77.19	Revenue / diluted weighted shares.
FCF per share	$3.06	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.11	Cash from operations / diluted weighted shares.
Book value per share	$15.70	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$6.85	Tangible book value / shares outstanding.
Cash per share	$1.63	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$6.62B	Share price x shares outstanding.
Enterprise value	$6.24B	Market cap + total debt - cash - short-term investments.
P/E	12.1x	Market cap / net income. Only when net income is positive.
P/S	0.36x	Market cap / revenue.
P/B	1.77x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	4.05x	Market cap / tangible book value, when positive.
P/FCF	9.06x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.42x	Market cap / cash from operations, when positive.
EV/Sales	0.34x	Enterprise value / revenue.
EV/EBIT	6.74x	Enterprise value / operating income, when both are positive.
EV/EBITDA	4.44x	Enterprise value / EBITDA, when both are positive.
EV/FCF	8.53x	Enterprise value / free cash flow, when both are positive.
FCF yield	11.0%	Free cash flow / market cap.
Earnings yield	8.2%	Net income / market cap (the inverse of P/E).
PEG	0.90x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was PILGRIMS PRIDE CORP's revenue in fiscal 2025?

PILGRIMS PRIDE CORP reported revenue of $18.50B for fiscal 2025, 3.5% higher than the year before.

Was PILGRIMS PRIDE CORP profitable in fiscal 2025?

Yes. Net income was $1.08B, a net margin of 5.9%.

How much free cash flow did PILGRIMS PRIDE CORP generate in fiscal 2025?

Cash from operations of $1.37B minus capital expenditures of $718.5M left free cash flow of $653.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to PILGRIMS PRIDE CORP